Molecule Details
| InChIKey | UNGSBCKKKYIIJC-UHFFFAOYSA-N |
|---|---|
| Compound Name | [5-Bromo-4-(3-isopropyl-1H-pyrazol-4-yl)-pyrimidin-2-yl]-(1-methyl-piperidin-4-yl)-amine |
| Canonical SMILES | CC(C)c1n[nH]cc1-c1nc(NC2CCN(C)CC2)ncc1Br |
| Clinical Status | Clinical Multi-Target |
| Targets (Human+Pathogen) | 6 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 6.22 |
| Source | ChEMBL;BindingDB;TTD_MultiTarget |
2D Structure
Activity Profile
Target Activities (6)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P06493 | CDK1 | Homo sapiens | Human | PF00069 | 6.3 | pIC50 | TTD_MultiTarget |
| P11802 | CDK4 | Homo sapiens | Human | PF00069 | 6.3 | pIC50 | TTD_MultiTarget |
| P24385 | CCND1 | Homo sapiens | Human | PF02984 PF00134 | 6.3 | IC50 | ChEMBL |
| P24941 | CDK2 | Homo sapiens | Human | PF00069 | 6.3 | pIC50 | TTD_MultiTarget |
| P30281 | CCND3 | Homo sapiens | Human | PF02984 PF00134 | 6.1 | IC50 | ChEMBL |
| Q00534 | CDK6 | Homo sapiens | Human | PF00069 | 6.1 | IC50 | ChEMBL;BindingDB |